Sommaire

• • ·Editorial Board

    Page :i

    

• International SFN meeting 2016

  • ·Foreword

    Page :537-538

    B. Eymard, J.-P. Camdessanché

    Résumé Résumé Plan Plan

• Muscular pathologies

  • ·What have we learned about glycogenosis in recent years?

    Page :541-545

    P. Laforêt

    Résumé Résumé Plan Plan  
  • ·RYR1-related rhabdomyolysis: A common but probably underdiagnosed manifestation of skeletal muscle ryanodine receptor dysfunction

    Page :546-558

    N.C. Voermans, M. Snoeck, H. Jungbluth

    Résumé Résumé Plan Plan  
  • ·Exercise training in metabolic myopathies

    Page :559-565

    J. Vissing

    Résumé Résumé Plan Plan  
  • ·Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach

    Page :566-571

    F. Fatehi, E. Salort-Campana, A. Le Troter, D. Bendahan, S. Attarian

    Résumé Résumé Plan Plan  
  • ·Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification

    Page :572-580

    M. De Antonio, C. Dogan, D. Hamroun, M. Mati, S. Zerrouki, B. Eymard, S. Katsahian, G. Bassez, French Myotonic Dystrophy Clinical Network 1

    Résumé Résumé Plan Plan  
  • ·Sporadic inclusion-body myositis: Recent advances and the state of the art in 2016

    Page :581-586

    L. Gallay, P. Petiot

    Résumé Résumé Plan Plan
  • ·Myofibrillar and distal myopathies

    Page :587-593

    J. Palmio, B. Udd

    Résumé Résumé Plan Plan  
  • ·Cardiac arrhythmia and late-onset muscle weakness caused by a myofibrillar myopathy with unusual histopathological features due to a novel missense mutation in FLNC

    Page :594-606

    D. Avila-Smirnow, L. Gueneau, S. Batonnet-Pichon, F. Delort, H.-M. Bécane, K. Claeys, M. Beuvin, B. Goudeau, J.-P. Jais, I. Nelson, P. Richard, R. Ben Yaou, N.B. Romero, K. Wahbi, S. Mathis, T. Voit, D. Furst, P. van der Ven, R. Gil, P. Vicart, M. Fardeau, G. Bonne, A. Behin

    Résumé Résumé Plan Plan  
  • ·Intermediate filaments in peripheral nervous system: Their expression, dysfunction and diseases

    Page :607-613

    A. Parlakian, D. Paulin, A. Izmiryan, Z. Xue, Z. Li

    Résumé Résumé Plan Plan  
  • ·Nemaline myopathies: State of the art

    Page :614-619

    E. Malfatti, N.B. Romero

    Résumé Résumé Plan Plan  

• Peripheral nerve pathologies

  • ·Regarding the past, what is the trial you have always been dreaming of in CIDP?

    Page :620-626

    R.A.C. Hughes, M.P.T. Lunn

    Résumé Résumé Plan Plan
  • ·Between genetics and biology. Is ENMG useful in peripheral neuropathy diagnosis and management?

    Page :627-631

    E. Stålberg

    Résumé Résumé Plan Plan  
  • ·Guillain-Barré syndrome: What have we learnt during one century? A personal historical perspective

    Page :632-644

    A. Uncini

    Résumé Résumé Plan Plan  
  • ·Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment?

    Page :645-652

    D. Adams, G. Beaudonnet, C. Adam, C. Lacroix, M. Théaudin, C. Cauquil, C. Labeyrie

    Résumé Résumé Plan Plan